Case Studies on RhD Genotyping in Pregnancy is organized by American Association of Blood Banks (AABB) and will be held on Jul 11, 2018.
The target audience for this medical event is Facilities that perform molecular testing, Hospitals, Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Medical Directors, Physicians, Resident/Fellow, Students (MD, MT, SBB), Technologists.
Clarification of the underlying genotype of pregnant patients that have weak D phenotypes is important for pregnancy management including a need for Rh Immune Globulin prophylaxis and red cell selection if transfusion is indicated. Current guidelines describe recommendations for the application of molecular RhD testing in this setting. This one-hour case based program will review current recommendations for molecular RhD testing and illustrate how this testing guides the management of pregnant patients with serological weak D.
After participating in this educational activity, participants should be able to:
• Explain current testing recommendations for management of pregnant women who have serological weak D.
• Discover how molecular testing can clarify serologic weak D testing results.
• Examine patient cases where molecular RhD testing guided pregnancy management.
Additional details will be posted as soon as they are available.
Obstetrics and Gynecology, Midwifery, Genetics